Bioventus BVS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $27.27M+158% | -$47.05M+75.9% | -$195.63M+8.3% | -$213.39M-6,062% | ||
| $47.01M-5.1% | $49.56M-13.6% | $57.37M+3.6% | $55.4M+58.8% | ||
| $12.67M-4.5% | $13.27M+388% | $2.72M-84.5% | $17.59M-11.4% | ||
| $74.67M+92.5% | $38.8M— | —— | —— | ||
| $2.56M+155% | $1.01M-86.3% | $7.36M— | —— | ||
| -$3.25M-114% | $22.96M— | —— | -$116.44M+59.0% | ||
| $45M+200% | $15M-69.4% | $49M+96.0% | $25M+25.0% | ||
| -$62.14M-13.1% | -$54.94M— | —— | $67.51M— | ||
| $9.66M— | —— | $5.13M+108% | -$67.38M— | ||
| $72.11M+90.8% | $37.79M+373% | $7.98M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bioventus generate?
- Bioventus (BVS) generated $102.9M in operating cash flow over the trailing twelve months.
- What is Bioventus's free cash flow?
- After $2.3M of capital expenditures, Bioventus's free cash flow was $100.6M over the trailing twelve months, up 320.5% year over year.
- Where does Bioventus's cash flow data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
